Matinas Biopharma Holdings Inc Stock News

BEDMINSTER, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to participate

Matinas Biopharma Holdings, Inc. (MTNB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Matinas BioPharma (MTNB) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

Two Sigma Advisers LP bought a new stake in Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) during the first quarter, according to the company in its most recent disclosure with the Securities and

On Wall Street, some things never change. Public health crisis or not, the fact of the matter remains that healthcare stocks are the epitome of risk/reward plays. Why? It comes down to the nature of t

State Street Corp boosted its position in shares of Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) by 658.7% in the first quarter, according to its most recent filing with the Securities and Excha

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) * ADC Therapeutics SA (NYSE: ADCT) * Akebia Therapeu

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC Therapeutics SA (NYSE:...

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that it has commenced enrollment and started dosing patients in the ENHANCE-IT study and that it expects to resume dosing patients i

Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB) gapped up prior to trading on Wednesday . The stock had previously closed at $0.95, but opened at $0.89. Matinas BioPharma shares last traded at $0.8

In this article we will take a look at whether hedge funds think Matinas Biopharma Holdings, Inc. (NYSE:MTNB) is a good investment right now. We check hedge fund and billionaire investor sentiment bef

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), today announced that Jerome D. Jabbour, Chief Executive Officer, has been invited to present a company overview during the Jefferies Virtual Healthc

Whilst it may not be a huge deal, we thought it was good to see that the Matinas BioPharma Holdings, Inc...

As of late, it has definitely been a great time to be an investor of Matinas BioPharma

Q1 2020 Matinas BioPharma Holdings Inc Earnings Call